Skip to main content
Log in

Anorexia Nervosa with Markedly High Bone Turnover and Hyperphosphatemia During Refeeding Rectified by Denosumab

  • Case Report
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

We describe a unique case of hyperphosphatemia associated with a very high bone turnover rate in a 51-year-old postmenopausal woman with undiagnosed anorexia nervosa (AN) who presented with a low-trauma hip fracture. In view of her severely malnourished state, she was not fit for surgery. She was treated according to a refeeding protocol that mandated bed rest. Contrary to expectation, she developed sustained hyperphosphatemia and borderline hypercalcemia. Bone remodelling markers, both resorption and formation, were markedly elevated. Parathyroid hormone (PTH) was low-normal at 1.7 pmol/L, C-terminal fibroblast growth factor 23 (FGF23) was high at 293 RU/ml, but tubular maximum reabsorption of phosphate (TmPO4/GFR) was elevated at 1.93 mmol/L. Denosumab 60 mg was administered that was followed by: rapid normalisation of serum phosphate; normalisation of resorption markers, transient hypocalcaemia with secondary hyperparathyroidism, and normalisation of both TmPO4/GFR and C-terminal FGF23. We speculate that prolonged immobilization as part of AN management led to a high remodelling state followed by hyperphosphatemia and high-normal calcium with appropriate suppression of PTH and that marked hyperphosphatemia and high TmP/GFR despite high FGF23 indicates the necessity of PTH adequacy for excess FGF23 to lower TmP/GFR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Psychiatric Association (1994) Quick reference to the diagnostic criteria from DSM-IV-TR. American Psychiatric Association, Washington

    Google Scholar 

  2. Lucas AR, Beard CM, O'Fallon WM, Kurland LT (1991) 50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry 148:917–922

    Article  CAS  Google Scholar 

  3. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, Herzog D, Klibanski A (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133:790–794

    Article  CAS  Google Scholar 

  4. Nagata JM, Golden NH, Leonard MB, Copelovitch L, Denburg MR (2017) Assessment of sex differences in fracture risk among patients with anorexia nervosa: a population-based cohort study using the health improvement network. J Bone Miner Res 32:1082–1089

    Article  CAS  Google Scholar 

  5. The Royal College of Psychiatrists (2014) MARSIPAN: Management of really sick patients with anorexia nervosa. 2nd edn

  6. Fukuoka H, Nishimura Y, Haruna M, Suzuki Y, Oyama K, Igawa S, Sekiguchi C, Murai T, Shigematsu T, Sudoh M, Akimura H, Gunji A (1997) Effect of bed rest immobilization on metabolic turnover of bone and bone mineral density. J Gravit Physiol 4:S75–S81

    CAS  PubMed  Google Scholar 

  7. Bikle DD, Halloran BP (1999) The response of bone to unloading. J Bone Miner Metab 17:233–244

    Article  CAS  Google Scholar 

  8. Doty SB, DiCarlo EF (1995) Pathophysiology of immobilization osteoporosis. Curr Opin Orthop 6:45–49

    Article  CAS  Google Scholar 

  9. Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N, Eastell R (2019) The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: the T-score bone marker approach in the TRIO study. Bone 131:115158

    Article  Google Scholar 

  10. Yoon BH, Yu W (2018) Clinical utility of biochemical marker of bone turnover: fracture risk prediction and bone healing. J Bone Metab 25:73–78

    Article  Google Scholar 

  11. Erben RG, Andrukhova O (2015) FGF23 regulation of renal tubular solute transport. Curr Opin Nephrol Hypertens 24:450–456

    Article  CAS  Google Scholar 

  12. Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT (2007) Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 22:931–937

    Article  CAS  Google Scholar 

  13. Crowley RK, Kilbane M, King TF, Morrin M, O'Keane M, McKenna MJ (2014) Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report. J Med Case Rep 8:84

    Article  Google Scholar 

  14. McKenna MJ, Martin-Grace J, Crowley R, Twomey PJ, Kilbane MT (2019) Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy. J Bone Miner Metab 37:685–693

    Article  CAS  Google Scholar 

  15. Smith D, Murray BF, McDermott E, O'Shea D, McKenna MJ, McKenna TJ (2005) Hungry bones without hypocalcaemia following parathyroidectomy. J Bone Miner Metab 23:514–515

    Article  Google Scholar 

  16. Misra M, Miller KK, Bjornson J, Hackman A, Aggarwal A, Chung J, Ott M, Herzog DB, Johnson ML, Klibanski A (2003) Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88:5615–5623

    Article  CAS  Google Scholar 

  17. Lieberman SA, Holloway L, Marcus R, Hoffman AR (1994) Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women. J Bone Miner Res 9:1723–1728

    Article  CAS  Google Scholar 

  18. Takuwa Y, Yamamoto M, Matsumoto T, Hata K, Ogata E (1986) Hyperphosphatemia after surgical correction of hypercortisolism in patients with Cushing's syndrome. Miner Electrolyte Metab 12:119–124

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. T. Kilbane.

Ethics declarations

Conflicts of interest

Dr. McKenna has received fees for lectures or advice from: Amgen, Clonmel Healthcare, Mylan, Pharmacosmos and UCB. None the other authors have any disclosures.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kilbane, M., Crowley, R., Twomey, P. et al. Anorexia Nervosa with Markedly High Bone Turnover and Hyperphosphatemia During Refeeding Rectified by Denosumab. Osteoporos Int 31, 1395–1398 (2020). https://doi.org/10.1007/s00198-020-05307-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-020-05307-1

Keywords

Navigation